Sjoquist KM, Espinoza D, Mileshkin L, Ananda S, et al. REZOLVE (ANZGOG-1101): A phase 2 trial of intraperitoneal bevacizumab to treat symptomatic ascites in patients with chemotherapy-resistant, epithelial ovarian cancer. Gynecol Oncol 2021 Feb 23. pii: S0090-8258(21)00109.
PMID: 33637349